Picture of Bioventix logo

BVXP Bioventix Income Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedSmall CapHigh Flyer

Annual income statement for Bioventix, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
UAS
UAS
UAS
UAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue8.759.2910.310.911.7
Cost of Revenue
Gross Profit8.188.419.4910.111
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses1.922.362.132.842.45
Operating Profit6.836.938.188.099.27
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes6.876.978.238.129.28
Provision for Income Taxes
Net Income After Taxes5.665.867.26.737.67
Net Income Before Extraordinary Items
Net Income5.665.867.26.737.67
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income5.665.867.26.737.67
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.081.121.381.281.46
Dividends per Share
Special Dividends per Share

Or unlock with your email

Or unlock with your email